Corix Bioscience Stock Debt To Equity
| CXBS Stock | USD 0.0001 0.00 0.00% |
Fundamental analysis of Corix Bioscience allows traders to better anticipate movements in Corix Bioscience's stock price by examining its financial health and performance throughout various phases of its business cycle.
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Corix Bioscience Company Debt To Equity Analysis
Corix Bioscience's Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.
Current Corix Bioscience Debt To Equity | 0.01 % |
Most of Corix Bioscience's fundamental indicators, such as Debt To Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Corix Bioscience is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
High Debt to Equity ratio typically indicates that a firm has been borrowing aggressively to finance its growth and as a result may experience a burden of additional interest expense. This may reduce earnings or future growth. On the other hand a small D/E ratio may indicate that a company is not taking enough advantage from financial leverage. Debt to Equity ratio measures how the company is leveraging borrowing against the capital invested by the owners.
| Competition |
According to the company disclosure, Corix Bioscience has a Debt To Equity of 0.014%. This is 99.97% lower than that of the Healthcare sector and 99.98% lower than that of the Drug Manufacturers - Specialty & Generic industry. The debt to equity for all United States stocks is 99.97% higher than that of the company.
Corix Debt To Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Corix Bioscience's direct or indirect competition against its Debt To Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Corix Bioscience could also be used in its relative valuation, which is a method of valuing Corix Bioscience by comparing valuation metrics of similar companies.Corix Bioscience is currently under evaluation in debt to equity category among its peers.
Corix Fundamentals
| Current Valuation | 820.28 K | |||
| Shares Outstanding | 27.34 M | |||
| Price To Book | 0.19 X | |||
| Price To Sales | 0.43 X | |||
| Revenue | 693.62 K | |||
| EBITDA | (3.31 M) | |||
| Net Income | (4.43 M) | |||
| Cash And Equivalents | 360.87 K | |||
| Cash Per Share | 0.01 X | |||
| Total Debt | 5.08 M | |||
| Debt To Equity | 0.01 % | |||
| Current Ratio | 0.16 X | |||
| Book Value Per Share | 0.17 X | |||
| Cash Flow From Operations | (1.85 M) | |||
| Beta | -1.51 | |||
| Market Capitalization | 820.28 K | |||
| Total Asset | 11.37 M | |||
| Retained Earnings | (12.42 M) | |||
| Net Asset | 11.37 M |
About Corix Bioscience Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Corix Bioscience's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Corix Bioscience using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Corix Bioscience based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Corix Stock Analysis
When running Corix Bioscience's price analysis, check to measure Corix Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Corix Bioscience is operating at the current time. Most of Corix Bioscience's value examination focuses on studying past and present price action to predict the probability of Corix Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Corix Bioscience's price. Additionally, you may evaluate how the addition of Corix Bioscience to your portfolios can decrease your overall portfolio volatility.